A FAMILIAL METABOLIC DISORDER WITH STORAGE OF AN UNUSUAL POLYSACCHARIDE COMPLEX

PEDIATRICS ◽  
1958 ◽  
Vol 22 (1) ◽  
pp. 20-32
Author(s):  
John M. Craig ◽  
L. Lahut Uzman

A metabolic disease, characterized by the accumulation of a mixture of complex polysaccharides in liver, spleen, lung, kidney and reticuloendothelial system, is described in three patients. Its familial nature is indicated by the fact that two of the cases were siblings. The salient clinical features included hepatosplenomegaly, anemia, failure in physical development and susceptibility to respiratory infection. The disease simulates glycogen storage disease in the response in the epinephrine tolerance test, and in an inability to call on glycogen stores. Histochemical tests on the tissue containing the storage cells indicated that the material was not glycogen, even though polysaccharide in nature. The storage material was isolated from the liver of one of the cases. This isolated material proved to be a complex consisting of two major moieties. The first appeared to possess a high molecular weight, was insoluble in organic solvents, and contained glucose, galactose, glucosamine and hexuronic acids as constituents. A small amount of peptides were associated with this fraction. The second major moiety of the storage material was soluble in ethanol and contained glucose, galactose, glucosamine, fatty acids, hexuronic acids and neuraminic acid as main constituents (hence a lipopolysaccharide). Attention is drawn to the fact that the storage material would have been considered an "abnormal glycogen" if the customary procedures for the isolation of glycogen had been applied to the tissue. It is suggested that caution be exercised in future studies involving storage diseases where storage of an "abnormal glycogen" with an abnormality in side-chains is suspected.

2012 ◽  
Vol 43 (6) ◽  
pp. 943-951 ◽  
Author(s):  
Pilar L. Magoulas ◽  
Ayman W. El-Hattab ◽  
Angshumoy Roy ◽  
Deeksha S. Bali ◽  
Milton J. Finegold ◽  
...  

PEDIATRICS ◽  
1981 ◽  
Vol 67 (1) ◽  
pp. 107-112
Author(s):  
C. Baussan ◽  
N. Moatti ◽  
M. Odievre ◽  
A. Lemonnier

Investigated were 24 cases of glycogenosis caused by a reduction in liver phosphorylase activity. The intravenous glucagon tolerance test could not discriminate between phosphorylase kinase deficiency [glycogen storage disease (GSD) IX] and phosphorylase deficiency (GSD VI). These two subgroups were distinguished by hemolysate enzyme assays: (1) GSD IX was characterized by a residual phosphorylase kinase activity, a low activation curve for endogenous phosphorylase b and increased amylo-1,6-glucosidase activity. (2) GSD VI was characterized by a normal or increased phosphorylase kinase activity, a slight activation of endogenous phosphorylase b and a normal amylo-1,6-glucosidase activity.


PEDIATRICS ◽  
1957 ◽  
Vol 19 (4) ◽  
pp. 585-595
Author(s):  
Robert Schwartz ◽  
James Ashmore ◽  
Albert E. Renold

Observations on a 3-month old infant with hypoglycemia and hepatomegaly from hepatorenal glycogen storage disease are reported. The diagnosis was based on analysis of the liver as well as typical clinical and laboratory findings. The liver histologically showed accumulation of glycogen and fat and biochemically was found to be deficient in glucose-6-phosphatase. An oral galactose tolerance test resulted in lactic acidosis with failure to detect any galactose or rise in concentration of glucose in the blood. An intravenous galactose tolerance test on two occasions resulted in the normal disappearance of galactose; however the concentration of glucose remained unchanged or declined, and that of lactate rose. The intravenous galactose test offers a further means for evaluating the glycolytic pathways in the liver in glycogen storage disease.


1985 ◽  
Vol 231 (3) ◽  
pp. 755-759 ◽  
Author(s):  
D G Clark ◽  
M Brinkman ◽  
S D Neville ◽  
W D Haynes

Intraperitoneal injection of 3-mercaptopicolinate into 24 h-food-deprived 27-week-old female control (GSD/GSD) rats lowered the concentration of circulating glucose by 66%, but glycerol and lactate concentrations were increased up to 3- and 4-fold respectively. In phosphorylase b kinase-deficient (gsd/gsd) rats the corresponding changes for blood glucose, lactate and glycerol were half those observed in the controls. Although the concentration of liver glycogen (approx. 12%, w/w) in the gsd/gsd rats was not altered during food deprivation, total hepatic glycogen was decreased by 17%. It is suggested that the gradual breakdown of the extensive hepatic glycogen stores during starvation assists in the maintenance of normoglycaemia in the gsd/gsd rat.


Author(s):  
F. G. Zaki ◽  
J. A. Greenlee ◽  
C. H. Keysser

Nuclear inclusion bodies seen in human liver cells may appear in light microscopy as deposits of fat or glycogen resulting from various diseases such as diabetes, hepatitis, cholestasis or glycogen storage disease. These deposits have been also encountered in experimental liver injury and in our animals subjected to nutritional deficiencies, drug intoxication and hepatocarcinogens. Sometimes these deposits fail to demonstrate the presence of fat or glycogen and show PAS negative reaction. Such deposits are considered as viral products.Electron microscopic studies of these nuclei revealed that such inclusion bodies were not products of the nucleus per se but were mere segments of endoplasmic reticulum trapped inside invaginating nuclei (Fig. 1-3).


Author(s):  
W. Jurecka ◽  
W. Gebhart ◽  
H. Lassmann

Diagnosis of metabolic storage disease can be established by the determination of enzymes or storage material in blood, urine, or several tissues or by clinical parameters. Identification of the accumulated storage products is possible by biochemical analysis of isolated material, by histochemical demonstration in sections, or by ultrastructural demonstration of typical inclusion bodies. In order to determine the significance of such inclusions in human skin biopsies several types of metabolic storage disease were investigated. The following results were obtained.In MPS type I (Pfaundler-Hurler-Syndrome), type II (Hunter-Syndrome), and type V (Ullrich-Scheie-Syndrome) mainly “empty” vacuoles were found in skin fibroblasts, in Schwann cells, keratinocytes and macrophages (Dorfmann and Matalon 1972). In addition, prominent vacuolisation was found in eccrine sweat glands. The storage material could be preserved in part by fixation with cetylpyridiniumchloride and was also present within fibroblasts grown in tissue culture.


Sign in / Sign up

Export Citation Format

Share Document